vTv Therapeutics Inc (VTVT)
27.84
-0.04
(-0.14%)
USD |
NASDAQ |
May 17, 16:00
27.84
0.00 (0.00%)
After-Hours: 20:00
vTv Therapeutics Accounts Receivable (Quarterly): 0.981M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.981M |
December 31, 2023 | 0.102M |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.173M |
September 30, 2022 | 0.057M |
June 30, 2022 | 0.077M |
March 31, 2022 | 0.057M |
December 31, 2021 | 0.057M |
September 30, 2021 | 0.928M |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.002M |
December 31, 2020 | 0.158M |
September 30, 2020 | 0.014M |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.005M |
December 31, 2019 | 0.005M |
September 30, 2019 | 0.01M |
Date | Value |
---|---|
June 30, 2019 | 1.822M |
March 31, 2019 | |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
June 30, 2018 | 2.27M |
March 31, 2018 | 0.21M |
December 31, 2017 | 8.00M |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.206M |
December 31, 2015 | 0.069M |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | 0.60M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2020
1.822M
Maximum
Jun 2019
0.2224M
Average
0.0355M
Median
Accounts Receivable (Quarterly) Benchmarks
Altimmune Inc | 0.307M |
Palatin Technologies Inc | 0.00 |
Oragenics Inc | -- |
Viking Therapeutics Inc | -- |
G1 Therapeutics Inc | 11.65M |